What if a medicine you thought of as “old news” suddenly showed up in new research with fresh benefits that might stretch well beyond its original purpose? That’s exactly the twist happening with a ...

Modern medical research shows that drug and surgical treatments for benign prostatic hyperplasia and chronic prostatitis carry high risks, while Dr Allen's Device, developed by Fine Treatment, an ...

A prescription medication that has been available in the U.S. since 1992 might have another significant benefit.

Detailed price information for Medicus Pharma Ltd (MDCX-Q) from The Globe and Mail including charting and trades.

Phase 2 Study Demonstrated 73% clinical Clearance in the 200-µg Arm suggests that ~3 out of 4 treated lesions may allow patients to avoid ...

I can’t get a good night’s sleep.”  After much cajoling, I got her to call her primary care provider who told her, as I had, that she most likely has an overactive bladder (OAB). An appointment was ...

UCLA and Stanford Medicine researchers, in collaboration with scientists from the University of Utah and Columbia University, ...

While sales of Talzenna, which Pfizer acquired in a $14 billion deal, have been “negligible” so far, the new results should ...

Discover six prostate cancer companies advancing the next generation of therapies for all stages of the disease.

Top experts share the latest bladder, kidney and prostate cancer advances from the 2026 ASCO GU Symposium, highlighting ...

Researchers at Texas A&M Health have identified a molecular mechanism that increases cholesterol levels inside prostate ...